On ECHEMI
Home > Drugs > Theophylline Sodium Glycine Sustained Release Tablets

Theophylline Sodium Glycine Sustained Release Tablets

Function and Efficacy

Not yet clear.

Appearance

White or off-white tablets.

Indication

It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.

Usage and Dosage

Oral administration: Adults, 1 tablet at a time, 3 times a day, after meals or as directed by a doctor.

Adverse Reactions

Not yet clear.

Precautions

1. Patients who are allergic to this product, active peptic ulcers and uncontrolled convulsive diseases are contraindicated; 2. Patients over 55 years old should use it with caution; 3. The plasma clearance rate of newborns may be reduced and the serum concentration may increase, so it should be used with caution. Children over 12 years old should follow the doctor's advice when using it; 4. Pregnant women, parturients and lactating women should use it with caution.

Special Population Medication

Precautions for children: Use with caution in newborns. Precautions for pregnancy and lactation: Use with caution in pregnant women, parturients and lactating women. Precautions for the elderly: Use with caution in patients over 55 years old.

Drug Interactions

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

Storage

seal.

Packaging Specification

0.1g (calculated as anhydrous theophylline)

Validity Period

24 months

Manufacturer

Jiangsu Pingguang Pharmaceutical (Jiaozuo) Co., Ltd.

  • Founded in:

    1998-03-11
  • Address:

    Shenzhou Road, Jiaozuo City Urban-Rural Integration Demonstration Zone
  • Tax NO.:

    91410800173475469M
  • Registered Funds:

    11.065 million yuan
  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.